Clinical Trial: A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Administration in Healthy Volunteers

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular A

Brief Summary: This proof-of-concept study evaluates the clinical efficacy and safety of DCN01 in prepping of the periocular region.

Detailed Summary:
Sponsor: Deacon Biosciences, Inc.

Current Primary Outcome: Change from baseline in periocular region bacterial load [ Time Frame: Baseline to 10 min post dose ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Proportion of periocular regions with a reduction from baseline in bacterial load. [ Time Frame: Baseline to 10 min post dose ]

Original Secondary Outcome: Same as current

Information By: Deacon Biosciences, Inc.

Dates:
Date Received: May 8, 2013
Date Started: April 2013
Date Completion:
Last Updated: January 19, 2016
Last Verified: January 2016